Fortitude Biomedicines
Cambridge, United States· Est. 2021
Develops novel small molecule therapies targeting RNA for neurological and neuromuscular diseases.
Private Company
Total funding raised: $75M
About
Develops novel small molecule therapies targeting RNA for neurological and neuromuscular diseases.
AntibodiesBiologics
Funding History
1Total raised:$75M
Series A$75MMar 15, 2023